Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.

Détails

ID Serval
serval:BIB_30CE534E379D
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
Périodique
European journal of gastroenterology & hepatology
Auteur(s)
Fraga M., Fournier N., Safroneeva E., Pittet V., Godat S., Straumann A., Nydegger A., Vavricka S.R., Moradpour D., Schoepfer A.M.
Collaborateur(s)
Swiss IBD Cohort Study Group
ISSN
1473-5687 (Electronic)
ISSN-L
0954-691X
Statut éditorial
Publié
Date de publication
01/2017
Peer-reviewed
Oui
Volume
29
Numéro
1
Pages
91-97
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Primary sclerosing cholangitis (PSC) represents the most common hepatobiliary extraintestinal manifestation of inflammatory bowel disease (IBD). We aimed to assess the prevalence of PSC in the Swiss Inflammatory Bowel Disease Cohort Study, to identify associated risk factors, and to describe the long-term evolution.
Data of patients enrolled into the Swiss Inflammatory Bowel Disease Cohort Study were analyzed. Logistic regression modeling was performed to identify risk factors for PSC.
Among 2744 patients [1188 ulcerative colitis (UC); 1556 Crohn's disease (CD)], 57 had PSC (48 UC-PSC, nine CD-PSC). The prevalence of PSC was higher in UC compared with CD (4.04 vs. 0.58%, P<0.001). We identified the following significant independent risk factors for PSC in patients with UC: male sex [odds ratio (OR) 2.771, P=0.022], pancolitis (OR 2.855, P=0.011), nonsmoker at diagnosis (OR 9.253, P=0.030), and a history of appendicectomy (OR 4.114, P=0.019). During a median follow-up time of 74.8 months, four (7.0%) of PSC patients developed cholangiocarcinoma, six (10.5%) underwent liver transplantation, and five (8.8%) died. Survival of IBD-PSC patients was significantly worse compared with IBD patients without PSC (P=0.001). UC-PSC patients developed significantly more frequently colorectal cancer compared with UC patients without PSC (2/48 vs. 9/1440, P=0.017).
Approximately 4% of UC patients and 0.6% of CD patients had PSC. Male sex, pancolitis, nonsmoker status, and a history of appendicectomy were significantly associated with PSC. PSC is associated with considerable morbidity and mortality in the long term.

Mots-clé
Adolescent, Adult, Age of Onset, Appendectomy/adverse effects, Chi-Square Distribution, Child, Cholangitis, Sclerosing/diagnosis, Cholangitis, Sclerosing/epidemiology, Cholangitis, Sclerosing/mortality, Cholangitis, Sclerosing/therapy, Colitis, Ulcerative/diagnosis, Colitis, Ulcerative/epidemiology, Colitis, Ulcerative/mortality, Colitis, Ulcerative/therapy, Crohn Disease/diagnosis, Crohn Disease/epidemiology, Crohn Disease/mortality, Crohn Disease/therapy, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Logistic Models, Male, Middle Aged, Multivariate Analysis, Odds Ratio, Prevalence, Risk Factors, Sex Factors, Smoking/epidemiology, Switzerland/epidemiology, Time Factors, Young Adult
Pubmed
Web of science
Création de la notice
21/09/2016 8:37
Dernière modification de la notice
20/08/2019 13:15
Données d'usage